Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function.
about
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac deathAmiodarone versus other pharmacological interventions for prevention of sudden cardiac deathDebate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop.Ventricular arrhythmias in congestive heart failure: clinical significance and managementPalpitations and arrhythmias. Separating the benign from the dangerous.[Risk stratification for sudden cardiac death in ischemic heart disease. Programmed ventricular stimulation].Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction.[Safe and unsafe indications to the electrophysiological examination]Data-driven Decisions: The Importance of Clinical Trials in Arrhythmia Management.Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy.Amiodarone: what have we learned from clinical trials?Prophylactic defibrillator implantation in patients with coronary artery disease.Diagnosis and management of ventricular tachycardiaLong-term prognosis after myocardial infarction. Who is at risk for sudden death?Comparative follow up of patients with implanted cardioverter-defibrillators after induction of sustained monomorphic ventricular tachycardias or ventricular fibrillation by programmed stimulationIncidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator.Evolution of the implantable cardioverter defibrillator.Sudden cardiac death: mechanisms, therapies and challenges.Ventricular arrhythmias: risk stratification and approach to therapy after the Cardiac Arrhythmia Suppression Trial (CAST).Future studies with the implantable cardioverter defibrillator.Antiarrhythmic drug therapy in congestive heart failure. Indications and complications.Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration: the Karolinska approach.Surgery for ventricular tachycardia and left ventricular aneurysm provides arrhythmia control.Ventricular arrhythmias. When should they be suppressed?Visualizing Nerve Injury in a Neuropathic Pain Model with [18F]FTC-146 PET/MRI.Value of prophylactic implantable cardioverter defibrillator therapy.The clinical significance of nonsustained ventricular tachycardia: current perspectives.Treatment of ventricular arrhythmias in older adults.The clinical significance of nonsustained ventricular tachycardia.Should electrophysiological studies be performed in asymptomatic patients following myocardial infarction? A pragmatic approach.Antiarrhythmic drug therapy for ventricular arrhythmias: current perspectives.Risk of ventricular arrhythmias in survivors of myocardial infarction.The top ten fallacies of nonsustained ventricular tachycardia.Reflections on Recent Clinical Trials in Patients With Heart Failure and Those With Reduced Ventricular Function.Implantable cardioverter defibrillator: the promise and perils of an evolving technology.Inducible ventricular arrhythmias and patency of infarct-related artery in survivors of acute myocardial infarction.Infarct characteristics by CMR identifies substrate for monomorphic VT in post-MI patients with relatively preserved systolic function and ns-VT.The evolution of the implantable cardioverter defibrillator.Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest.
P2860
Q24187185-F570EEE1-1A0A-4074-80BA-D24E4207D8C6Q24240892-134A807F-F75E-47FD-B4DE-D402DABC2286Q24792670-4E8092BB-300C-4F36-9302-A953BDF0068DQ30433543-F609147A-6168-4D46-92CD-94DA2C98A439Q33144673-B987FA5C-82D1-4C85-8949-27FD0A7B9C3BQ33154790-D3055697-8737-4B26-B1A5-1236FAA91E66Q33165392-23631A6D-68F2-459A-9584-C850DB1197D6Q33175341-89C68D9F-88F7-44BE-9E37-FADF965D45EBQ33175903-7912DB05-25F8-4A04-B620-2462436FBF27Q33179799-B042D8DF-8422-44DC-8FAC-8E6CB7E56278Q33612175-BF694810-0893-4F1B-9C50-4CBB4733B022Q33838684-A5B305C4-1A66-4F94-B0F2-DCA1E9BA96FCQ34011190-F38DBB08-DF9D-4C74-8E50-7ABC915655D2Q35531009-CE7657E8-0154-413A-8B05-12B2491819D4Q35555651-F11E4405-0B11-4EDE-A8AB-7307F7555792Q35581151-278D3E30-C146-46EC-8E8F-4E29DA2C3D69Q35582397-48C7DBDA-C8DA-4F3E-ADC8-3B0679966EC0Q35696656-F8297FCE-413E-4D34-9CFD-F3614984939BQ36304357-A74477FD-05FA-487A-9E10-C351E6EE9C10Q36616330-588C133F-9428-4BC0-BF65-8491ED8B4132Q36662487-143A2640-C942-45D7-BA0C-3DA10C92BA2AQ36819603-C43F0C2F-E7E0-409B-A4A1-FF0327CD7395Q36935395-7F9530FA-20A5-4C57-84E5-FAA4EC64B387Q37196876-696A1AC3-C046-4AF9-B6C1-BBF80645F0BBQ37213800-7BA70982-0579-484B-8013-2B319B792C8AQ39151193-483F57F0-95B9-4040-AAA8-1554770AC8DCQ40388774-E3732B05-3B6D-4E5C-A047-5A67615FAB71Q40390031-8875D12A-A85E-4F32-8D56-8369FCF20F98Q40401401-524410A3-BA05-4BB2-8F5C-913E0DEF1C4FQ40795052-AF7DDD4E-90E4-4D40-8DD5-0FBB92343E89Q41031313-ED1D9FDD-E008-446D-9885-4EDB26605708Q41112408-02DB3984-A01A-4DA4-BC52-C0A26448E216Q41633750-4269643F-63B1-458D-AB78-DF8F5D903628Q41657624-CDAD44E9-4B11-4802-9C0C-6D1DEB486E64Q41720838-FB90008E-9993-47BC-8178-FE919E19FFEFQ43564739-2C2CC11A-A839-4889-9D69-B26F2A5A1A3DQ43840694-E136A6B3-06CE-4841-B3C3-3AA77BA6EA10Q44814217-5843FEB4-6163-4F76-93E4-8E0F8905856AQ46878706-71A28AA0-626F-49FE-B451-80C47D34006CQ51475926-775E23CB-E238-4CED-8E43-6424D02D1277
P2860
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Electrophysiological testing a ...... impaired ventricular function.
@en
type
label
Electrophysiological testing a ...... impaired ventricular function.
@en
prefLabel
Electrophysiological testing a ...... impaired ventricular function.
@en
P2093
P356
P1433
P1476
Electrophysiological testing a ...... impaired ventricular function.
@en
P2093
P304
P356
10.1161/01.CIR.82.2.350
P407
P577
1990-08-01T00:00:00Z